Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
British Journal of Cancer
|
October 19, 2022
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
Shukui Qin, Jin Li, Haijun Zhong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2023
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
Ye Guo, Weijie Zhang, Jieer Ying, et al.
Cancer Communications (London, England)
|
April 4, 2019
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial
Jing Huang, Binghe Xu, Ying Liu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 1, 2018
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Zhihao Lu, Xiaotian Zhang, Wei Liu, et al.
BMC Gastroenterology
|
October 24, 2021
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study
Rongrui Liu, Lianke Liu, Chuanhua Zhao, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
Zhichao Tan, Yan Wu, Zhengfu Fan, et al.
BMC Cancer
|
February 7, 2023
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
Chuanliang Cui, Yu Chen, Zhiguo Luo, et al.
JAMA
|
February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
Xiaotian Zhang, Jufeng Wang, Gang Wang, et al.
The Oncologist
|
January 25, 2014
The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma
Jifang Gong, Bing Hu, Xiaotian Zhang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 4, 2021
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
Yingying Xu, Yakun Wang, Jifang Gong, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
British Journal of Cancer
|
October 19, 2022
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
Shukui Qin, Jin Li, Haijun Zhong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2023
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
Ye Guo, Weijie Zhang, Jieer Ying, et al.
Cancer Communications (London, England)
|
April 4, 2019
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial
Jing Huang, Binghe Xu, Ying Liu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 1, 2018
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Zhihao Lu, Xiaotian Zhang, Wei Liu, et al.
BMC Gastroenterology
|
October 24, 2021
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study
Rongrui Liu, Lianke Liu, Chuanhua Zhao, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
Zhichao Tan, Yan Wu, Zhengfu Fan, et al.
BMC Cancer
|
February 7, 2023
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
Chuanliang Cui, Yu Chen, Zhiguo Luo, et al.
JAMA
|
February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
Xiaotian Zhang, Jufeng Wang, Gang Wang, et al.
The Oncologist
|
January 25, 2014
The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma
Jifang Gong, Bing Hu, Xiaotian Zhang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 4, 2021
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
Yingying Xu, Yakun Wang, Jifang Gong, et al.
Page
of 11